CAP Gynecologic Biomarker Protocol: Testing and Reporting of Prognostic and Therapeutic Biomarkers

This interactive webinar will provide an overview of the CAP Gynecologic Biomarker Protocol released in December 2024. It will cover the testing rationale for prognostic and therapeutic biomarkers such as ER/PR, HER2, mismatch repair proteins, p53, PD-L1, and FOLR1, and explain how to integrate testing and reporting into your workflow. Participants will have the opportunity to ask questions and clarify any practical issues related to testing and synoptic reporting of gynecologic biomarkers.

Presented by CAP Cancer Protocol Authors Gulisa Turashvili, MD, PhD, FCAP, and Anthony N. Karnezis, MD, PhD, FCAP